Ioana Agache – EAACI President

Slides:



Advertisements
Similar presentations
A Global Framework for Public Health Functions Taskforce for World Federation of Public Health Associations Draft for discussion 15 th May 2014.
Advertisements

CUHP Cambridge University Health Partners (CUHP) unites a world-leading University and three high- performing NHS Foundation Trusts centred on the Cambridge.
1 Biomedical Sciences Public and Environmental Health Regenerative Medicine Translational Research.
CADTH Therapeutic Reviews
Health Stakeholder Consultation Event Frances Spillane, Assistant Secretary General Department of Health 11 March 2015.
Clinical Pharmacy Basma Y. Kentab MSc..
Access to Personalised Medicine for PDAC patients STSM of the application of an EU-index for barriers Denis Horgan (EAPM) & Angela Brand (IPHG) on behalf.
Clinical trials in Framework programme 7 (FP7) EU Judita Kinkorová 2. Národní konference o doporučených postupech, Olomouc 13. listopadu 2010.
The European Innovation Partnership for asthma: an opportunity for change Samantha Walker PhD, Asthma UK Project Coordinator, EARIP (European Asthma Research.
A 2 DAHT provides evidence-based, unbiased, reliable and trusted health technology assessments and Education for a better global healthcare. Our results.
PaRROT Program Introduction. Learning objectives Understand and be aware of: History, objectives principles and expected outcomes of PaRROT Program content,
Component 1: Introduction to Health Care and Public Health in the U.S. 1.9: Unit 9: The evolution and reform of healthcare in the US 1.9c: Quality Indicators.
The opportunities and challenges of sharing genomics data with the pharmaceutical industry Shahid Hanif, Head of Health Data & Outcomes, ABPI DNA digest.
Prepared by: Iris Abigail B. Navallo, RN MSN-MHPN CNIS 5807.
Dr Charmaine Gauci Superintendent of Public Health/Director General PH
Today’s managers & leaders are challenged unlike any of the past generations in their roles.
Nancy Mamo, Managing Director, Population Health Analytics, BCBSRI
Highly Preliminary Building a sustainable health and care system for the people of Sussex and East Surrey.
Global Health Competencies for UK Healthcare Professionals
Where is the Implementation in Implementation Science?
Knowledge for Healthcare: Driver Diagrams October 2016
MEP Interest Group on Brain, Mind and Pain
Health Technology Assessment
HEE Nursing Associate Programme
WHO’s prioritised research agenda for the prevention and control of NCDs prioritises
Workforce Priorities in the Nottinghamshire STP
Family Physician Desirable Competency
Clinical Studies Continuum
Improving Health Literacy Today….not Tomorrow”
Community Pharmacy: Sharing Our Vision
Malcolm Wright Chief Executive, NHS Grampian
National Service Framework (NSF) for Older People & Dignity in Care
Supporting Effective Public Services in Scotland.
Strategic Research Agenda
Healthy Towns and Place-Based Integration
Monterey County Health Department
“Next Generation of Connected Health”
سمینارآشنايی با مفاهيم خودارزيابی و سرآمدی سازمانی
Why & how to launch it in Lithuania?
Methodology and Corporate Architecture
Maximizing the value and the impact of health research in Europe
UCD School of Medicine & Medical Science
PWR Endorsed diploma work group
Jason Gerson, PhD Clinical Effectiveness and Decision Science
Johns Hopkins Medicine Innovation 2023 Strategic Plan
An initiative that makes a difference
Medical Research Funding and Regulation Third Annual Medical Research Summit March 6, 2003 Mary S. McCabe National Institutes of Health.
Towards Integrated Person Centered Health Service Delivery
Clinical and Translational Science Awards Program
Artificial Intelligence in the Health Sector
Health Technology Assessment for Universal Health Coverage
Kaisa Immonen EPF Director of Policy
Public health reform A Scotland where everybody thrives.
The Arizona Chronic Disease Plan:
Moving Forward Together Programme Overview
Raising the bar Meeting Europe’s future challenges
What research would you fund on smoke-free homes?
The Ottawa Charter as an Effective Health Promotion Framework - Overview As you learn about the Ottawa Charter as an effective health promotion framework.
Environment and Development Policy Section
EESC Public Hearing 30-Jan-2019
Johns Hopkins Medicine Innovation 2023 Strategic Plan
What is Moving Forward Together
NICE resources for STPs: MECC
Strategies to Guide, Motivate and Facilitate Change
Building PHN Scientists
Getting Knowledge into Action for Healthcare Quality
Clare Lewis Deputy Chief Nursing Officer Community
Realistic Prescribing Pathways
Impact of quality on day-to-day efforts of PHC
An Agency Perspective on Plain Language Summaries of Publications
Presentation transcript:

Ioana Agache – EAACI President Prioritising research challenges and funding for allergy, asthma and the need for translational research

EAACI vision for the management of allergy and asthma 3. Research priorities The developmental exposome Allergic diseases and asthma in the context of population and environmental health Drug development and biomedical engineering 1.Connect science with the transformation of care Big data and artificial intelligence Translational research and implementation science “omics”-technologies towards personalized therapeutic and prevention approaches E-Health and M-Health 2. Meet the changing needs of our stakeholders Standards and quality criteria Purposeful education Patient empowerment and patient centeredness 4. Grow in a sustainable way Clinical care pathways Harmonisation and standardisation 4 pillars

Key tools EAACI White Paper on Research, Innovation and Quality Care EAACI Guidelines, Consensus Documents Innovative educational portfolio Training, competencies, clinical decision support systems Health policies based on priorities and social equanimity 5Ps and 5Es of patient empowerement

Challenges and unmet needs (1) European legislation on environment control air quality smoking indoor and outdoor pollution invasive allergenic plants standard occupational exposure

Challenges and unmet needs (2) All patients should have easy access to new safe and effective drugs and other management options Reimbursement policies should ideally be aligned across European states

Challenges and unmet needs (3) Implementing precision/personalised medicine in the clinical setting Global, multi-discipline partnerships/the open collaborative approach/free knowledge exchange Rethinking healthcare Encourage “valuable” innovation and enterprises willing to assume the risk in developing precision-medicine approaches

Translational research – 3 steps Movement between basic research and patient-oriented research that leads to new or improved scientific understanding or standards of care. Movement between patient-oriented research and population-based research that leads to better patient outcomes, the implementation of best practices, and improved health status in communities. Interaction between laboratory-based research and population-based research to stimulate a robust scientific understanding of human health and disease.

Implementation science Promotes the systematic uptake of research findings and other evidence-based practices into routine practice, and, hence, to improve the quality and effectiveness of health services” Focus on the patient level, provider, organization, and policy levels of healthcare

The goal is to go further and do better